Back to 
Axxcess Wealth Management, LLC
Axxcess Wealth Management, LLC
HALO
Showing 0 of 2 quarters
Position history for Axxcess Wealth Management, LLC's holdings in Halozyme Therapeutics, Inc.
No. Axxcess Wealth Management exited its HALO (Halozyme Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 3,950 shares worth $224,755. Axxcess Wealth Management first reported HALO in Q4 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.